三博脑科拟参与投资设立天津元明海河脑科学创业投资合伙企业

Group 1 - The company, Sanbo Brain Science (301293.SZ), announced its plan to invest in the establishment of the Tianjin Yuanming Haihe Brain Science Venture Capital Partnership, aiming to enhance its clinical diagnosis and treatment capabilities while leveraging capital market advantages [1][2] - The total amount to be raised by the partnership is set at 300 million yuan, with the company committing 57 million yuan of its own funds to subscribe for partnership shares [1] - The partnership will focus on investing in leading enterprises in the brain science field, particularly in areas such as diagnosis, treatment, health management, and medical information technology, aligning with the company's core business in neurological medical services [2] Group 2 - The investment is expected to create synergies between the company's existing medical services and the targeted investments in advanced brain science technologies and related sectors [2] - The collaboration aims to achieve resource complementarity and broaden investment channels, enhancing the company's competitive edge in the market [2]